Conference Scene: ISOBM 2013 in Israel: part 1: biomarkers - where we are now?

Author： Topolcan Ondrej   Pesta Martin   Svobodova Sarka  

Publisher： Future Medicine

ISSN： 1752-0363

Source： Biomarkers in Medicine, Vol.7, Iss.3, 2013-06, pp. : 403-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conference Scene: ISOBM 2013 in Israel: part 2: biomarkers - a challenging issue for futher investigation

By Topolcan Ondrej   Pesta Martin   Svobodova Sarka  

Biomarkers in Medicine, Vol. 7, Iss. 3, 2013-06 ,pp. : 407-414

Future Medicine

Access to resources Recommend Favorite

The Role of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis. Where are we Now?

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 1, 2013-04 ,pp. : 70-78

Bentham Science Publishers

Access to resources Recommend Favorite

Fluid management for trauma; where are we now?

By Dutton Richard P  

BJA - CEPD Reviews, Vol. 6, Iss. 4, 2006-08 ,pp. : 144-147

Oxford University Press

Access to resources Recommend Favorite

Genetic association studies: where are we now?

By Savage Sharon A  

Personalized Medicine, Vol. 3, Iss. 4, 2006-11 ,pp. : 371-374

Future Medicine

Access to resources Recommend Favorite

Staging Acute Pancreatitis: Where Are We Now?

By  

Pancreatology, Vol. 1, Iss. 3, 2001-07 ,pp. : 201-206

Karger

Access to resources Recommend Favorite